Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases

NCT07077473 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2026-01-27

No results posted yet for this study

Summary

retrospective observe the efficacy and safety of different drugs used in familial Mediterranean fever (FMF) cases in real-world

Conditions

  • Familial Mediterranean Fever (FMF )

Interventions

DRUG

real word drugs

real word drugs

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Pfizer

    collaborator INDUSTRY
  • Johns Hopkins University

    collaborator OTHER
  • Tongji Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07077473 on ClinicalTrials.gov